The role of real-world data in advancement of Alzheimer’s treatments
One in nine Americans age 65 and older has Alzheimer’s disease (AD), a devastating illness that...
One in nine Americans age 65 and older has Alzheimer’s disease (AD), a devastating illness that...
Healthcare claims data are one of the most powerful sources of data in generating real-world...
Rare diseases may be individually uncommon, but collectively they affect an estimated 30 million...
Closed claims no longer reflect real-world GLP-1 treatment patterns GLP-1 utilization continues to...
Liver disease is a growing global health concern, yet many of its most serious forms remain under-recognized and underdiagnosed. Metabolic dysfunction-associated steatohepatitis (MASH) stands out as a particularly urgent challenge. MASH disease is a ...